Skip to content

The Clinical Application and Promotion of Neuroregulation Techniques in Geriatric Depression

The Clinical Application and Promotion of Neuroregulation Techniques in Geriatric Depression

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113883
Enrollment
Unknown
Registered
2025-12-04
Start date
2024-02-21
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Geriatric Depression

Interventions

A1:Routine parameters group of transcranial magnetic stimulation :The left dorsolateral prefrontal cortex (DLPFC), stimulated at 80% of the patients motor threshold, with a stimulation frequency of 10
A2:iTBS stimulation group:iTBS stimulation parameters: stimulation frequency of 3Hz, stimulation intensity at 120% of motor threshold, five sessions per week, each lasting 3 minutes, for a total of fo
A3:Sham - stimulation Group of Transcranial Magnetic Stimulation:Rotate the stimulating magnet 180° in relation to the scalp, keeping all other treatment parameters consistent with the A1 group.
B1:Vagus nerve stimulation intervention group:Psychiatrists trained the physicians responsible for this study. After disinfecting the ear area with alcohol, the physician placed the two ear clips of t
B2:Vagus nerve sham stimulation group:A pseudo-stimulation group was subjected to microcurrent stimulation without ta

Sponsors

Suzhou Guangji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Age: 60 to 85 years old; 2. After diagnosis by a professional physician, it meets the above-mentioned pathological diagnosis criteria for depression; 3. Have not received any treatment recently and suspend other treatment plans when receiving this treatment; 4. Be able to cooperate with all the steps of the trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Subjects who do not meet the diagnostic criteria and inclusion criteria; 2. Taking other psychiatric medications; 3. Age beyond the inclusion range; 4. Rule out severe heart, lung, kidney and liver diseases, bleeding tendencies and functional system changes; 5. Exclude the presence of other mental disorders; 6. Subjects currently participating in other clinical trials; 7. Subjects who do not cooperate with the trial and do not sign the informed consent form; 8. Fear of the test method, obvious boundary effect of oral drugs, and severe allergy.

Design outcomes

Secondary

MeasureTime frame
Assessment of cognitiion;

Primary

MeasureTime frame
Depressive assessment;Assessment of Anxiety Symptoms;

Countries

China

Contacts

Public ContactYang Xuna

Suzhou Guangji Hospital

yxn730202@126.com+86 189 6211 6897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026